Comparative safety of dolutegravir-based or efavirenz-based antiretroviral treatment started during pregnancy in Botswana: an observational study

• Главные авторы: Rebecca Zash, MD (Автор), Denise L Jacobson, PhD (Автор), Modiegi Diseko, BA (Автор), Gloria Mayondi, BSc (Автор), Mompati Mmalane, MD (Автор), Max Essex, ProfPhD (Автор), Tendani Gaolethe, MD (Автор), Chipo Petlo, BA (Автор), Shahin Lockman, MD (Автор), Lewis B Holmes, MD (Автор), Joseph Makhema, MBBS (Автор), Roger L Shapiro, MD (Автор)
• Формат: ‌
• Опубликовано: Elsevier, 2018-07-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Summary: Background: Global rollout of dolutegravir-based antiretroviral therapy (ART) has been hampered in part by insufficient safety data in pregnancy. We compared birth outcomes among women initiating dolutegravir-based ART with those among women initiating efavirenz-based ART in pregnancy in Bo...